Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Maraba virus as a potent oncolytic vaccine vectorJonathan G Pol, Liang Zhang, Byram W Bridle, et al.Journal of Leukocyte Biology|October 25, 2024
CD56 does not contribute to the antitumor, tissue homing, and glycolytic capacity of human NK cellsAna L Portillo, Eduardo A Rojas, Misaal Mehboob, et al.Molecular Immunology|February 10, 2015
Circulating TNF and mitochondrial DNA are major determinants of neutrophil phenotype in the advanced-age, frail elderlyChris P Verschoor, Dessi Loukov, Avee Naidoo, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapyByram W Bridle, Lan Chen, Chantal G Lemay, et al.Cancer Immunology Research|July 19, 2018
Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine ModelSophie M Poznanski, Tina Nham, Marianne V Chew, et al.Frontiers in Immunology|May 4, 2023
LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signalingArya Afsahi, Christopher M Silvestri, Allyson E Moore, et al.Oncoimmunology|September 25, 2025
IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapyAna L Portillo, Misaal Mehboob, Genesis Snyder, et al.Molecular Oncology|May 26, 2017
AMPK β1 reduces tumor progression and improves survival in p53 null miceVanessa P Houde, Sara Donzelli, Andrea Sacconi, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost VaccinationByram W Bridle, Andrew Nguyen, Omar Salem, et al.Cytotherapy|February 13, 2023
T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myelomaKsenia Bezverbnaya, Joanne A Hammill, Derek Cummings, et al.Pageof 11